about
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach ...
Read More
7.42
0.17
(2.34%)
3.4M
XNAS Volume
XNAS 06 Aug, 2026 11:41 AM (EDT)
Board Meeting
The next board meeting for ImmunityBio Inc is on 07 Aug 2026 for the purpose of ImmunityBio Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..